Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Compounding Theme Archive
INFUSION AND STERILE PREPARATIONS
INFUSION AND STERILE PREPARATIONS
A collection of Journal articles and formulations within one or more related compounding topics.

This archive contains the following articles listed by volume, issue and page number:

INFUSION RELATED ARTICLES
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Calculations
Stockton Shelly J
Sep/Oct 2023
Pg. 410

Comparison of Three Reconstitution Devices: A Simulated Time and Use Study
Penoyer Daleen
, Giuliano Karen, Middleton Aurea
Mar/Apr 2023
Pg. 169-174

Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags
Breukels Oscar
, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
Jul/Aug 2018
Pg. 345-349

U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)
Nov/Dec 2016
Pg. 457-458

Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Foushee Jaime A
, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Jul/Aug 2016
Pg. 328-332

Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump
Tomasello Cristina
, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio
Jul/Aug 2016
Pg. 343-346

Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration
Mody Vicky
, Shah Samit, Patel Jaymin, Thomas Michael C
May/Jun 2016
Pg. 236-238

Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment
Hecq Jean-Daniel
, Rolin Catherine, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Nov/Dec 2015
Pg. 521-524

In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers
Bhattacharya Sisir
, Parekh Satish, Dedhiya Mahendra
Sep/Oct 2015
Pg. 432-436

Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters
Puertos Enrique
, Spencer Melissa
Jul/Aug 2015
Pg. 334-336

Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
Jul/Aug 2014
Pg. 313-317

Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion
Allen Loyd V Jr
Nov/Dec 2011
Pg. 504

Home Infusion: Overview of the Infusion Patient-Care Process
Kennedy Steve
Jul/Aug 2011
Pg. 270-276

Stability of Ertapenem in an Elastomeric Infusion Device
Phipps Stephen D
, Peacock Gina F, Smith Douglas L
May/Jun 2011
Pg. 252-254

Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations
Jasti Bhaskara R
, Saraf Poonam
May/Jun 2011
Pg. 259-261

Home Infusion: Available Vascular Access Devices and Common Therapies
Kennedy Steve
, Williams LaVonn A
May/Jun 2011
Pg. 183-188

Home Infusion Basics for the Non-Infusion Pharmacist
Miron Karen E
Mar/Apr 2011
Pg. 94-100

Home Infusion Accreditation: Another Quality Recognition Branding Tool
Canally Sandra C
Sep/Oct 2010
Pg. 360-364

Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device
Tsiouris Maria
, Ulmer Marisa, Yurcho James F, Hooper Kevin L, Gui Min
Sep/Oct 2010
Pg. 436-439

Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C
, Ben Michel, Trusley Craig, Trissel Lawrence A
Mar/Apr 2008
Pg. 170-173

Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate
Trissel Lawrence A
, Zhang Yanping
Sep/Oct 2004
Pg. 398-403

Chemical Stability of Terbutaline Sulfate Injection After Diluting With Normal Saline When Stored at Room Temperature in Polyvinylchloride Bags
Gupta Vishnu D
Sep/Oct 2004
Pg. 404-406

A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Newton David W
, Trissel Lawrence A
Jul/Aug 2004
Pg. 251-263

Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours.
Musami Patrick
, Stewart James T, Taylor E Will
May/Jun 2004
Pg. 236-239

Hydromorphone HCl 20-mg/mL and Bupivacaine HCl 7.5-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2004
Pg. 136

Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion
Gupta Vishnu D
Mar/Apr 2004
Pg. 153-155

Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags
Lebrun John
, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M
Mar/Apr 2004
Pg. 156-159

PostScription: Cleanroom Standards
Fitzpatrick Mike
, Goldstein Ken
Mar/Apr 2004
Pg. 160

Hydrochloric Acid 0.1-N Injection
Allen Loyd V Jr
Jan/Feb 2004
Pg. 55

Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours
Musami Patrick
, Stewart James T, Taylor E Will
Jan/Feb 2004
Pg. 73-76

Chemical Stability of Cefuroxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D
Jul/Aug 2003
Pg. 310-312

Phenytoin Injections: From Compounding to Cerebyx
Newton David W
Nov/Dec 2002
Pg. 410-413

Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 1
Chamallas Stanley N
, Sullivan Kathleen
Nov/Dec 2002
Pg. 428-432

Total Parenteral Nutrition for Animals
Sammarco Domenic A
Sep/Oct 2002
Pg. 328-330

A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets
Rice Stephen P
Mar/Apr 2002
Pg. 120-122

Creating a Productivity Measurement Tool for a Home Infusion Pharmacy
Chamallas Stanley N
Jan/Feb 2002
Pg. 24-26

New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems
Kastango Eric S
, Hadaway Lynn
Jan/Feb 2002
Pg. 55-57

Ceftazidime 20-mg/mL for Ambulatory Infusion Pump
Allen Loyd V Jr
Nov/Dec 2001
Pg. 451

New Perspectives on Vancomycin Use in Home Care, Part 1
Kastango Eric S
, Hadaway Lynn
Nov/Dec 2001
Pg. 465-469

Stability of Ephedrine Sulfate at Ambient Temperature and 4°C in Polypropylene Syringes
Storms Meredith L
, Stewart James T, Warren Flynn W
Sep/Oct 2001
Pg. 394-396

Assessment of the Stability of Teicoplanin in Intravenous Infusions
Galanti Laurence M
, Hecq Jean-Daniel, Jeuniau Philippe, Vanbeckbergen Danielle, Jamart Jacques
Sep/Oct 2001
Pg. 397-400

PostScription: pH Values of Nafcillin Sodium in 0.9% Sodium Chloride Injection After the Addition of Sodium Bicarbonate Injection To Prevent Phlebitis - A Letter to the Editor
Gupta Vishnu D
Jul/Aug 2001
Pg. 328

Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs
Trissel Lawrence A
, Williams Kimberly Y, Baker Ma
Jan/Feb 2001
Pg. 69-73

Stability of Ethacrynate Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D
, Ling Jie
Jan/Feb 2001
Pg. 73-75

Stability of Acyclovir Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D
, Ling Jie
Jan/Feb 2001
Pg. 75-77

Disposable Ambulatory Infusion Devices: A Review - Part 3
Ashworth Lisa D
Nov/Dec 2000
Pg. 442-443

Ambulatory Syringe Infusion Devices: A Review - Part 2
Ashworth Lisa D
Sep/Oct 2000
Pg. 364

Short Communication: Compounding for Implantable Pumps
Molitor Richard
Jul/Aug 2000
Pg. 280

Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review
Ashworth Lisa D
Jul/Aug 2000
Pg. 281-285

Needleless Infusion Systems
Allen Loyd V Jr
, Mathews Elizabeth
May/Jun 2000
Pg. 183

Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration
Inagaki Kazuhiro
, Miyamoto Yuriko, Kurata Niroko, Nakane Shigeki, Gill Mark A, Nishida Mikio
Mar/Apr 2000
Pg. 150-153

Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection
Gupta Vishnu D
, Bailey RE
Jan/Feb 2000
Pg. 66-68

Electronically Controlled Drug Delivery
Kloesel Lawson
Nov/Dec 1999
Pg. 439-440

Compounding Radiolabeled Blood Cells for Diagnostic Imaging
Hinkle George H
Nov/Dec 1999
Pg. 443-446

Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C
Webster Andrew A
, English Brett A, McGuire J Michael, Riggs Robert M, Lander Vickie, Buckle Thomas
Sep/Oct 1999
Pg. 412-414

Catheter Occlusion: Causes and Solutions
McKinnon Barbara
, Lima Hetty A
Sep/Oct 1998
Pg. 342-346

TPN Bulk Compounding from Bulk Drug Substances
Chamallas Stanley N
Sep/Oct 1998
Pg. 347-349

The Feasibility and Benefits of TPN in Horses: A Review of the Findings
Paoletti James E
, Downing Dee, Tormo Vicente J
Sep/Oct 1998
Pg. 351-353

Model Parenteral Nutrition Formulation (Veterinary)
Allen Loyd V Jr
Sep/Oct 1998
Pg. 352

Required Documentation for Home Infusion Pharmacies - Compounding Records
Lima Hetty A
Sep/Oct 1998
Pg. 354-359

Adult Peripheral Parenteral Nutrition Solution with 4.23% Amino Acids
Allen Loyd V Jr
Sep/Oct 1998
Pg. 366

Adult Peripheral Parenteral Nutrition Solution with 2.5% Amino Acids
Allen Loyd V Jr
Sep/Oct 1998
Pg. 367

Three-in-One Adult Total Parenteral Nutrition
Allen Loyd V Jr
Sep/Oct 1998
Pg. 371

Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump
Xu Quanyun A
, Trissel Lawrence A
Sep/Oct 1998
Pg. 382-384

Stability of Magnesium Sulfate in 0.9% Sodium Chloride and Lactated Ringers Solutions
Sarver Jeffrey G
, Pryka Randy, Alexander Kenneth S, Weinstein Louis, Erhardt Paul W
Sep/Oct 1998
Pg. 385-388

Cleaning, Inspecting and Flow-Accuracy Testing of Ambulatory Pumps
Allen Loyd V Jr
Nov/Dec 1997
Pg. 430-431

Home Infusion and Alternative-Site Health Care: The Big Picture
Lima Hetty A
Sep/Oct 1997
Pg. 294-297

Continued Growth Predicted for Home Infusion Market
Allen Loyd V Jr
Sep/Oct 1997
Pg. 298

Drug Stability and Compatibility: Special Considerations for Home Health Care
Lima Hetty A
Sep/Oct 1997
Pg. 301-305

Ambulatory Infusion Pump Review
Allen Loyd V Jr
Sep/Oct 1997
Pg. 306-307

Effect of Fat Emulsion and Supersaturation in Parenteral Nutrition Admixtures
Fausel Christopher A
, Newton David W, Driscoll David F, Allen Loyd V Jr
Jan/Feb 1997
Pg. 54-59

Return to Top

STERILE PREPARATIONS RELATED ARTICLES
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
New USP Chapters <72> and <86> for Testing Pharmaceuticals for Sterility and Endotoxins
Ashworth Lisa D
Mar/Apr 2025
Pg. 116-119

Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations
Jan/Feb 2025
Pg. 38-39

Hand and Glove Sanitizing in Sterile Compounding, Part 1
Greeson Nicole MH
, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Nov/Dec 2024
Pg. 475-479

Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
Sep/Oct 2024
Pg. 358-362

Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S
, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
Sep/Oct 2024
Pg. 383-393

Sterile Basics of Compounding: Repackaging, Part 1
Allen Loyd V Jr
Jul/Aug 2024
Pg. 298-303

Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing
Akers Michael J
May/Jun 2024
Pg. 229-240

Sterile Filtration
Akers Michael J
Mar/Apr 2024
Pg. 120-127

Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S
, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
Jan/Feb 2024
Pg. 44-55

Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations
Allen Loyd V Jr
Nov/Dec 2023
Pg. 483-486

Hyaluronidase Injection
Allen Loyd V Jr
Nov/Dec 2023
Pg. 491

Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Allen Loyd V Jr
Sep/Oct 2023
Pg. 397-409

Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Allen Loyd V Jr
Jul/Aug 2023
Pg. 305-313

Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
May/Jun 2023
Pg. 223-229

Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility
Summers Amy
Mar/Apr 2023
Pg. 114-121

Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
Mar/Apr 2023
Pg. 123-139

Aminohippurate Sodium 250 mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2023
Pg. 142

Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes
de Wilde Sofieke
, Crul Mirjam, Breukels Oscar
Mar/Apr 2023
Pg. 154-159

Sterile Basics: How to Know if Your Cleanroom Can Consistently Operate Within a State of Control
Summers Amy
, Stephens Pat
Jan/Feb 2023
Pg. 39-46

Sterile Basics of Compounding: Contamination Control Strategies, Part 2
Summers Amy
Nov/Dec 2022
Pg. 497-504

Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding)
Allen Loyd V Jr
Nov/Dec 2022
Pg. 515

Sterile Basics of Compounding: Contamination Control Strategies, Part 1
Summers Amy
Sep/Oct 2022
Pg. 411-418

Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program
Summers Amy
Jul/Aug 2022
Pg. 309-315

Three Things You Need to Know Right Now
Brunner Scott
May/Jun 2022
Pg. 211-213

Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
May/Jun 2022
Pg. 219-228

Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine
Catry Emilie
, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
May/Jun 2022
Pg. 248-254

Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
Mar/Apr 2022
Pg. 118-126

Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation
Allen Loyd V Jr
Mar/Apr 2022
Pg. 129-136

Pharmacy Student Satisfaction and Perceptions Following a Virtual Sterile Compounding Experience
Mohammad Insaf
, Lobkovich Alison, Nardolillo Joseph, Wilhelm Shelia
Jan/Feb 2022
Pg. 10-17

Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Allen Loyd V Jr
Jan/Feb 2022
Pg. 41-49

Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021
Hecq Jean-Daniel
, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
Nov/Dec 2021
Pg. 446-462

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496

Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2
Higgins Doral (Neal) O
, Prudom Melanie J, Summers Amy
Sep/Oct 2021
Pg. 389-395

Expecting the Expected: Planning Considerations for Cleanroom Construction
Roberts Patricia A
, Kroon Laura
Jul/Aug 2021
Pg. 276-281

Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1
Higgins Doral (Neal) O
, Prudom Melanie J, Summers Amy
Jul/Aug 2021
Pg. 298-302

Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
Jul/Aug 2021
Pg. 311-317

Pharmacy Technicians' Perceptions of Risk Reduction Strategies Implemented in Response to the Repetitive Strain Injury Associated with Sterile Compounding
Zamani Mazdak
, Chan Kayin, Wilcox Julie
May/Jun 2021
Pg. 182-186

Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
May/Jun 2021
Pg. 222-229

PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
Mar/Apr 2021
Pg. 92

Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic
Roberts Patricia A
, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
Mar/Apr 2021
Pg. 109-113

Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139

Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
McKettrick Greg
, Yoch Doug
Jan/Feb 2021
Pg. 18-23

Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2021
Pg. 42

Establishing a Structured Pharmacy Training Program in Sterile Compounding
Dirbas Muhannad
, AbuSara Aseel K, Whiyabi Shatha, Harb Rema, Telfah Shorouq
Nov/Dec 2020
Pg. 460-465

Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
Nov/Dec 2020
Pg. 473-478

Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients
Nogales Luis Marcos
, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol
Sep/Oct 2020
Pg. 358-364

Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse)
Allen Loyd V Jr
Sep/Oct 2020
Pg. 406

Evaluation of the Efficacy and Superiority of Different Vial Rubber Closure Disinfection Techniques
Bjornstad Matthew
, Kosinski Tracy, Burlage Robert
Sep/Oct 2020
Pg. 434-438

Quality Control: Rapid Sterility Testing for Compounding Pharmacies
Taylor Andrew
Jul/Aug 2020
Pg. 299-303

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
Allen Loyd V Jr
Jul/Aug 2020
Pg. 305-309

Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review
Milibari Loay
, Cotugno Michael, Belisle Caryn, Rocchio Megan, Patterson Robert F, Chacon Pablo, Fanikos John, Vo Peter
Jul/Aug 2020
Pg. 346-351

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
Allen Loyd V Jr
May/Jun 2020
Pg. 215-220

Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities
Allen Loyd V Jr
Mar/Apr 2020
Pg. 121-126

How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems
Vaughn Stacey R
, Radwick Allison
Jan/Feb 2020
Pg. 14-19

Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50

Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators
Mulder Kyle
Nov/Dec 2019
Pg. 447-452

How to Qualify Container Closure Systems for Intended Use, Part 1
Kim Amy A
, Gehrmann Matthew R, McCaw James, McAndrew T Page
Nov/Dec 2019
Pg. 454-461

Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2
Greeson Nicole MH
, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Nov/Dec 2019
Pg. 467-471

Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
Nov/Dec 2019
Pg. 478-482

Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1
Greeson Nicole MH
, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Sep/Oct 2019
Pg. 387-391

Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
Sep/Oct 2019
Pg. 399-402

Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing
Allen Loyd V Jr
Jul/Aug 2019
Pg. 299-303

Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Allen Loyd V Jr
May/Jun 2019
Pg. 221-228

Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website
Sluggett Janet K
, Johnson Michelle J, Zamani Mazdak, Kastango Eric S, Bodnar Mark, Cantor Peter, Hobbs Jodie G, Reynolds Karen J, Sluggett Andrew J
May/Jun 2019
Pg. 238-244

Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
Allen Loyd V Jr
Mar/Apr 2019
Pg. 123-130

Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding
Martin Matt
Jan/Feb 2019
Pg. 47-49

Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2
Martin Matt
Nov/Dec 2018
Pg. 475-478

Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina
, Baskett Dustin
Sep/Oct 2018
Pg. 387-398

Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
Sep/Oct 2018
Pg. 401-404

Cysteamine 0.5% Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2018
Pg. 408

Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Martin Matt
Jul/Aug 2018
Pg. 303-312

Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding
Allen Loyd V Jr
May/Jun 2018
Pg. 206-217

Dorzolamide 2% Ophthalmic Solution
Allen Loyd V Jr
May/Jun 2018
Pg. 234

Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture
Allen Loyd V Jr
May/Jun 2018
Pg. 237

Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy
Rhoads Rick
Mar/Apr 2018
Pg. 129-134

Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution
Allen Loyd V Jr
Mar/Apr 2018
Pg. 147

Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture
Allen Loyd V Jr
Mar/Apr 2018
Pg. 151

Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy
Kosinski Tracy M
, Brown Michael C, Zavala Pedro J
Jan/Feb 2018
Pg. 41-46

Glutamate and Aspartate Cardioplegia Additive Solution
Allen Loyd V Jr
Jan/Feb 2018
Pg. 50

Sodium Citrate 9% Nasal Spray for Olfactory Disorders
Allen Loyd V Jr
Jan/Feb 2018
Pg. 57

Haloperidol 5-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2017
Pg. 493

Trace Elements Injection 5
Allen Loyd V Jr
Nov/Dec 2017
Pg. 498

Vancomycin 5-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2017
Pg. 499

Basics of Sterile Compounding: Particulate Matter
Akers Michael J
Sep/Oct 2017
Pg. 395-404

Acetylcysteine Solutions for Inhalation
Allen Loyd V Jr
Sep/Oct 2017
Pg. 408

Etoposide 20-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 410

Fentanyl Citrate 50-mcg/mL Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 411

Ioversol Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 413

Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose
Allen Loyd V Jr
Sep/Oct 2017
Pg. 415

Tacrolimus 0.3-mg/mL Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2017
Pg. 416

Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes
Kirkham Kylian
, Munson Jessica M, McCluskey Susan V, Graner Kevin K
Sep/Oct 2017
Pg. 426-429

Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags
Marquis Kathleen
, Hohlfelder Benjamin, Szumita Paul M
Sep/Oct 2017
Pg. 436-439

Component Selection for Sterile Compounding
Dilzer Richard H
Jul/Aug 2017
Pg. 277-280

Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
Jul/Aug 2017
Pg. 301-308

Reteplase Injection
Allen Loyd V Jr
Jul/Aug 2017
Pg. 317

Tacrolimus 0.06% Ophthalmic Drops
Allen Loyd V Jr
Jul/Aug 2017
Pg. 319

Torsemide 10-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2017
Pg. 320

Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding
Ligugnana Roberto
May/Jun 2017
Pg. 182-190

Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Mixon William
, Roth Abby
May/Jun 2017
Pg. 193-203

Basics of Sterile Compounding: Manipulating Peptides and Proteins
Akers Michael J
May/Jun 2017
Pg. 223-228

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

Accuracy Considerations in Sterile Compounding
Akers Michael J
Mar/Apr 2017
Pg. 133-142

Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers
McCluskey Susan V
, Kirkham Kylian, Munson Jessica M
Mar/Apr 2017
Pg. 150-153

Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
Jan/Feb 2017
Pg. 47-56

Infliximab 1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2017
Pg. 62

Tetracaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2017
Pg. 64

Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
Nov/Dec 2016
Pg. 495-500

Flumazenil 0.1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2016
Pg. 509

Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
Sep/Oct 2016
Pg. 399-404

Inamrinone 5-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2016
Pg. 408

Tromethamine Injection
Allen Loyd V Jr
Sep/Oct 2016
Pg. 415

Choosing a Vial Processing Line for Aseptic Compounding: Part 1
Noorian Shaun
, Vahedi Navid
Jul/Aug 2016
Pg. 283-292

Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding
Akers Michael J
Jul/Aug 2016
Pg. 307-314

Dolasetron Mesylate 20-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2016
Pg. 318

Gatifloxacin 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 319

Plasmingen and Hyaluronate Sodium Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 325

Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 326

Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Akers Michael J
May/Jun 2016
Pg. 217-222

Carboplatin 50-mg/mL Injection
Allen Loyd V Jr
May/Jun 2016
Pg. 226

Cefotetan Disodium Injection
Allen Loyd V Jr
May/Jun 2016
Pg. 227

Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
May/Jun 2016
Pg. 228

Sodium Nitroprusside 25-mg/mL Injection
Allen Loyd V Jr
May/Jun 2016
Pg. 234

Root Cause Analysis, Part 2: Sterile Compounding
Cabaleiro Joe
, Jackson Kathleen
Mar/Apr 2016
Pg. 99-104

Formulation and Stability of Solutions
Akers Michael J
Jan/Feb 2016
Pg. 41-45

Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
Jan/Feb 2016
Pg. 51

Thrombin 1,000 Units/mL Topical Solution, Sterile
Allen Loyd V Jr
Jan/Feb 2016
Pg. 54

Tropicamide 1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2016
Pg. 55

Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2016
Pg. 56

Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Akers Michael J
Nov/Dec 2015
Pg. 491-500

Cefepime Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2015
Pg. 505

Cefotaxime 100-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2015
Pg. 506

Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
Nov/Dec 2015
Pg. 507

Estradiol Valerate 40-mg/mL in Oil Injection
Allen Loyd V Jr
Nov/Dec 2015
Pg. 509

Levetiracetam 100-mg/mL Injection (Concentrate)
Allen Loyd V Jr
Nov/Dec 2015
Pg. 510

Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations
Donnelly Ronald F
Sep/Oct 2015
Pg. 383-386

Sterile Filtration
Akers Michael J
Sep/Oct 2015
Pg. 393-401

Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S
, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
Jul/Aug 2015
Pg. 268-278

Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing
Akers Michael J
Jul/Aug 2015
Pg. 315-320

Ammonium Molybdate 25-mcg/mL Injection
Allen Loyd V
Jul/Aug 2015
Pg. 324

Cytarabine 50-mg/mL Injection
Allen Loyd V
Jul/Aug 2015
Pg. 328

Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection
Allen Loyd V
Jul/Aug 2015
Pg. 329

Oxytocin 10-units/mL Injection
Allen Loyd V
Jul/Aug 2015
Pg. 330

Phytonadione 2-mg/mL Injection
Allen Loyd V
Jul/Aug 2015
Pg. 331

Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities
Weller Tom
, Kragseth Rolf, Dullinger Roger, Illum Henrik, Perry Alan
May/Jun 2015
Pg. 182-192

Quality Assurance and Quality Control, Part 2
Akers Michael J
May/Jun 2015
Pg. 215-221

Basics of Sterile Compounding: Contamination Control
Akers Michael J
May/Jun 2015
Pg. 232-238

Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
May/Jun 2015
Pg. 246

Scopolamine Hydrobromide -.4-mg/mL Injection
Allen Loyd V Jr
May/Jun 2015
Pg. 247

Protocol of Blood Serum Eye Drops
Katsakoulas Ioannis
, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
May/Jun 2015
Pg. 252-260

Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials
Mueller Claudia
, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
May/Jun 2015
Pg. 261-267

New England Compounding Center Indictment
Cabaleiro Joe
Mar/Apr 2015
Pg. 94-102

Quality Assurance and Quality Control, Part 1
Akers Michael J
Mar/Apr 2015
Pg. 121-124

Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing
Akers Michael J
Mar/Apr 2015
Pg. 127-138

Aminohippurate Sodium 200-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 143

L-Cysteine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 146

Morrhuate Sodium 5% Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 147

Pancuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 149

Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 150

Trypan Blue 0.06% Ophthalmic Solution
Allen Loyd V Jr
Mar/Apr 2015
Pg. 151

Basics of Sterile Compounding: Aseptic Processing
Akers Michael J
Jan/Feb 2015
Pg. 49-56

Cisplatin 1-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 62

Daunorubicin 5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 63

Erythromycin 50-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 64

Hydralazine Hydrochloride 20-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 65

Phentolamine Mesylate 5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 69

PreScription: "Named Formulas" Database Available
Allen Loyd V Jr
Nov/Dec 2014
Pg. 444

Depyrogenation Options for the Compounding Cleanroom
Weller Tom
, Bell Jeff, Dullinger Roger, Allen Vern, Anthenat Bruce
Nov/Dec 2014
Pg. 446-454

Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms
Akers Michael J
Nov/Dec 2014
Pg. 479-484

Dexmedetomidine 100 mcg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 495

Leucovorin 10-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 497

Levocarnitine 200-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 498

Methylene Blue 10-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 500

Oxacillin Sodium 167-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 502

Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy
Palma Elisabetta
, Bufarini Celestino
Sep/Oct 2014
Pg. 358-364

Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know
Lanze Amanda
, Rudner Shara
Sep/Oct 2014
Pg. 397-399

Azithromycin 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 408

Dexpanthenol 250-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 410

Ephedrine Sulfate 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 411

Fluorescein 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 412

Indocyanine green 2.5-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 413

Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety
Johnson Kain
, Sully Andrew, Anthenat Bruce
Jul/Aug 2014
Pg. 270-276

Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
Jul/Aug 2014
Pg. 313-317

Atracurium Besylate 10-mg/mL Injection, Preserved
Allen Loyd V Jr
Jul/Aug 2014
Pg. 322

Calcitriol 1-mcg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 324

Chloramphenicol 100-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 325

Indigo Carmine Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 329

Propranolol Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 330

Zinc 1-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 331

Bupivacaine Hydrochloride 0.5% Injection
Allen Loyd V Jr
May/Jun 2014
Pg. 234

Lidocaine Hydrochloride 1% Injection
Allen Loyd V Jr
May/Jun 2014
Pg. 237

A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
Mar/Apr 2014
Pg. 94-99

Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding
Vu Nicole
, Nguyen Devin, Kupiec Thomas C
Mar/Apr 2014
Pg. 123-130

Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume
Allen Loyd V Jr
Mar/Apr 2014
Pg. 131-134

Fludarabine Phosphate 25-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 143

Mecasermin 10-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 144

Methylprednisolone 40-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 145

Polymixin B Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 146

Rocuronium Bromide 10-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 147

Selenium 40-mcg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 149

Sincalide 1-mcg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 150

Testosterone Enanthate 200-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 151

The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene
, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2014
Pg. 6-12

Determination of Risk for Sterile Preparations
Freedman ben-Horin Shimon
, Rousso Tamaro
Jan/Feb 2014
Pg. 30-34

Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding
Hyde Tiffany D
Jan/Feb 2014
Pg. 46-52

Basics of Sterile Compounding: Bubble Point Testing
Thoma Laura
Jan/Feb 2014
Pg. 54-57

Aztreonam Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 60

Bumetanide 0.25-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 61

Droperidol 2.5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 62

Potassium Chloride 2-mEq/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 67

Procainamide Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 68

Vasopressin 20-units/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 69

Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies
Brensel Robert
, Brensel Scott, Ng Amy
Nov/Dec 2013
Pg. 465-475

Benztropine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2013
Pg. 498

Cefazolin 250-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2013
Pg. 499

Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2013
Pg. 502

Dihydroergotamine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2013
Pg. 503

Compounding Pharmacies: Before and After an Inspection
Kulkarni Darshan
, Ricketts Samantha
Sep/Oct 2013
Pg. 358-362

Acyclovir 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 414

Aminocaproic Acid 250-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 415

Clindamycin 150-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 416

Fluorouracil 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 417

Hydroxyzine Hydrochloride 25-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 418

Indomethacin 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 419

Mesna 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 420

Methotrexate 25-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 421

Phenylephrine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 422

Terbutaline Sulfate 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 423

United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013
Newton David W
Jul/Aug 2013
Pg. 283-288

Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
Jul/Aug 2013
Pg. 307-311

Allopurinol Sodium 4-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 328

Amikacin Sulfate 250-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 329

Dacarbazine 200-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 330

Ketamine 50-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 331

Methohexital Sodium 500-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 332

Metoprolol Tartrate 1-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 333

Succinylcholine Chloride 50-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 335

Decontamination Technology: The Missing Element
Rahe Hank
May/Jun 2013
Pg. 193-199

Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines
Weatherman Kara D
, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
May/Jun 2013
Pg. 238-246

Sterilization of Compounded Parenteral Products: Verification of Autoclaves
Rahe Hank
Mar/Apr 2013
Pg. 94-98

Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program
Griffiths Tricia
, Connors Anne
Mar/Apr 2013
Pg. 130-134

Basics of Compounding: Repackaging, Part 2
Allen Loyd V Jr
Mar/Apr 2013
Pg. 136-140

Adenosine 3-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 144

Alcohol Dehydrated Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 145

Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate
Allen Loyd V Jr
Mar/Apr 2013
Pg. 147

Cyanocobalamin 1000-mcg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 148

Dexrazoxane 1-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 149

Meropenem 50-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 150

Paclitaxel 6-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 151

Thiotepa 15-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 152

Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings
Weatherman Kara D
, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
Mar/Apr 2013
Pg. 168-174

Basics of Compounding: Repackaging, Part 1
Allen Loyd V Jr
Jan/Feb 2013
Pg. 54-60

Desmopressin 4-mcg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 64

Dobutamine 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 65

Granisetron 1-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 66

Ibuprofen 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 67

Mepivacaine Hydrochloride 1% Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 68

Milrinone 0.2-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 69

Neostigmine Methylsulfate 0.5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 70

Nicardipine Hydrochloride Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 71

Octreotide 50-mcg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 72

Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 73

Aminophylline 25-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 500

Ammonium Chloride 5-mEq/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 501

Azathioprine 10-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 502

Copper 0.4-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 503

Dipyridamole 5-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 504

Dopamine Hydrochloride 80-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 505

Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules
Allen Loyd V Jr
Nov/Dec 2012
Pg. 506

Papaverine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 507

Valproate Sodium 100-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 508

Vercuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 509

Metronidazole 5-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 425

Doxapram Hydrochloride 20-mg/mL injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 418

Enalaprilat 1.25-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 419

Esmolol Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 420

Fluconazole 2-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 421

Haloperidol 50-mg/mL in Oil Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 422

Meperidine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 423

Methocarbamol 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 424

Nalbuphine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 426

Oxymorphone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 427

I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease
McElhiney Linda F
May/Jun 2012
Pg. 190-195

PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone
Cabaleiro Joe
Jan/Feb 2012
Pg. 86-87

Misinterpretation of United States Pharmacopeia Chapter <797>
McElhiney Linda F
Jan/Feb 2012
Pg. 6-10

Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons
James Kate
, Allred Richard, Latta Kenneth S, McElhiney Linda F, Olson Jacob, Hall Richard M, Baker Chad, Armstrong Nicholas, Janik Peter, Whitehead Paul, Purcell Julian
Sep/Oct 2011
Pg. 390-407

Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions
Schnatz Rick
, Hernandex-Cardoso Antonio
May/Jun 2011
Pg. 224-232

Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1
Latta Kenneth S
, Cabaleiro Joe, Whitehead Paul, Edison Doug
Mar/Apr 2011
Pg. 133-144

PreScription: The Resources of the International Journal of Pharmaceutical Compounding, Inc.; Sterile Compounding Meets Needs for Patients, Professionals
Allen Loyd V Jr
, Menighan Thomas E
Jan/Feb 2011
Pg. 4

A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management
Robinson Marian
Jan/Feb 2011
Pg. 20-26

Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations
Cooper James F
Jan/Feb 2011
Pg. 49-54

Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 2
Cooper James F
, Chakrabarty Kaushik, McGuire Jason, Zolner William J, Jones Vann, Hedman Hilary
Nov/Dec 2010
Pg. 493-506

Home Infusion: Overcoming the Barriers to Entry
Franklin David M
Nov/Dec 2010
Pg. 450-455

Implementation of a Viable Air-Sampling Program Using a Volumetric Collection Device
Kennedy Steve
, Siefert Lisa Linn, Lange Matt
Sep/Oct 2010
Pg. 370-372

Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1
Dubczak John
, Latta Kenneth S, Hedman Hilary, Smith Donald R
Sep/Oct 2010
Pg. 407-414

PostScription: Guidance to Achieve Accreditation from the Pharmacy Compounding Accreditation Board
Pharmacy Compounding Accreditation Board
Sep/Oct 2010
Pg. 440-441

PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals
Menighan Thomas E
Jul/Aug 2010
Pg. 268

Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together
McElhiney Linda F
Jul/Aug 2010
Pg. 270-274

Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters
Dawson Michael E
Jul/Aug 2010
Pg. 317-320

Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program
Okeke Claudia C
, Allen Loyd V Jr
Jul/Aug 2010
Pg. 328-331

Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations
Okeke Claudia C
, Allen Loyd V Jr
May/Jun 2010
Pg. 232-238

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests
Allen Loyd V Jr
, Okeke Claudia C
Mar/Apr 2010
Pg. 142-149

Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector
Khondkar Dristi
, Chopra Poonam, McArter John P, Rosen Joseph A, Li S Kevin
Mar/Apr 2010
Pg. 160-164

Ophthalmic Toning-Lubricating Drops
Allen Loyd V Jr
Jan/Feb 2010
Pg. 70

An Academic Practice Partnership: An Innovative Course in Advanced Compounding
Hale Katherine S
, Hammer Dana P, Needham Shawn, Lawhorn Michelle Gaster
Jan/Feb 2010
Pg. 48-53

Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control
Okeke Claudia C
, Allen Loyd V Jr
Jan/Feb 2010
Pg. 60-64

Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Mixon William
, Angelle Patricea (Patsy), Chang Richard I
Nov/Dec 2009
Pg. 506-515

Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops
Reed-Kane Dana
, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
Nov/Dec 2009
Pg. 540-543

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 16: Suggested Standard Operating Procedures
Okeke Claudia C
, Allen Loyd V Jr
Nov/Dec 2009
Pg. 546-553

Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes
Bailey Caroline
, Aloumanis Vasileios, Walker Brian, Ben Michel, McGuire Jason, Vu Nicole
Nov/Dec 2009
Pg. 564-568

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing
Okeke Claudia C
, Allen Loyd V Jr
Sep/Oct 2009
Pg. 420-426

Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients
Mixon Bill
, Ille Gary
Jul/Aug 2009
Pg. 290-294

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued)
Okeke Claudia C
, Allen Loyd V Jr
Jul/Aug 2009
Pg. 322-329

PostScription: Compounding Pharmacy in Puerto Rico
Lopez Marisol
Jul/Aug 2009
Pg. 350-351

Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting
McElhiney Linda F
Jul/Aug 2009
Pg. 300-310

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control
Allen Loyd V Jr
, Okeke Claudia C
May/Jun 2009
Pg. 234-238

Compliance by Hospitals and Healthcare Facilities with the Revised United States Pharmacopeia Chapter <797>
McElhiney Linda F
Mar/Apr 2009
Pg. 94-98

Tips for Cleanroom Construction and Renovation
Mixon William
, Huffman Lanny
Mar/Apr 2009
Pg. 100-104

Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations
Latta Kenneth S
, Howard Betty, Gordon Ken, Foster Lisa, Nichols Larry, Floyd Dan B, Winters Martell, Bryans Trabue
Mar/Apr 2009
Pg. 106-119

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 12: Sterilization Methods
Allen Loyd V Jr
, Okeke Claudia C
Mar/Apr 2009
Pg. 146-150

Acidified Sodium Hypochlorite for Antisepsis and Disinfection
Allen Loyd V Jr
Mar/Apr 2009
Pg. 152

Quality Control Analytical Methods: Testing of Electrolytes Solutions
Vu Nicole
Jan/Feb 2009
Pg. 53-55

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Allen Loyd V Jr
, Okeke Claudia C
Jan/Feb 2009
Pg. 56-62

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations
Allen Loyd V Jr
, Okeke Claudia C
Sep/Oct 2008
Pg. 440-443

Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations
Trissel Lawrence A
Nov/Dec 2008
Pg. 524-528

Glycerin, Sterile
Allen Loyd V Jr
Nov/Dec 2008
Pg. 542

Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale
Okeke Claudia C
, Newton David W, Kastango Eric S, Allen Loyd V Jr
Nov/Dec 2008
Pg. 530-536

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Allen Loyd V Jr
, Okeke Claudia C
Jul/Aug 2008
Pg. 344-353

Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists
Mixon Bill
, Cabaleiro Joe, Latta Kenneth S, Vail Jane
Jul/Aug 2008
Pg. 321-327

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use
Allen Loyd V Jr
, Okeke Claudia C
May/Jun 2008
Pg. 252-257

Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards
Kastango Eric S
May/Jun 2008
Pg. 216-229

Dilution and Compounding of Ziconotide for Intrathecal Administration
Buchta Tony
, Fakata Keri, Stuart William
May/Jun 2008
Pg. 200-207

Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm!
Odegard Russell D
Mar/Apr 2008
Pg. 130-135

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Allen Loyd V Jr
, Okeke Claudia C
Mar/Apr 2008
Pg. 136-144

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations
Allen Loyd V Jr
, Okeke Claudia C
Jan/Feb 2008
Pg. 54-60

Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study
Peters Gregory F
, McKeon Marghi R, Nerbun Richard G
Nov/Dec 2007
Pg. 450-470

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics
Allen Loyd V Jr
, Okeke Claudia C
Nov/Dec 2007
Pg. 492-499

Calculations: High-Technology Compounding and Investigational Dispensing
Webb Sheldon D
, Stockton Shelly J
Nov/Dec 2007
Pg. 500-501

Standard Operating Procedure: Vial Crimper--Use, Care, Cleaning, and Maintenance
Allen Loyd V Jr
Nov/Dec 2007
Pg. 502-503

Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests
Kupiec Thomas C
Sep/Oct 2007
Pg. 400-403

Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr
, Okeke Claudia C
Sep/Oct 2007
Pg. 404-410

Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution
Allen Loyd V Jr
Jul/Aug 2007
Pg. 328

Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Okeke Claudia C
Jul/Aug 2007
Pg. 302-305

Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2
Allen Loyd V Jr
, Okeke Claudia C
Jul/Aug 2007
Pg. 314-323

Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution
Allen Loyd V Jr
Jul/Aug 2007
Pg. 335

Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1
Allen Loyd V Jr
, Okeke Claudia C
May/Jun 2007
Pg. 230-236

Quality Control Analytical Methods: The Quality of Sterility Testing
McGuire Jason
, Kupiec Thomas C
Jan/Feb 2007
Pg. 52-55

BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle
Benischek Rita L
Nov/Dec 2006
Pg. 428-433

Quality-Control Analytical Methods: Sterility Failure Investigations
Venti Eden M
Sep/Oct 2006
Pg. 372-375

Teaching Lab Renovation: University of Texas at Austin College of Pharmacy Combines Sterile and Nonsterile Compounding Lab Spaces
Acosta W Renee
, Salzman Robert D
Jul/Aug 2006
Pg. 277-280

Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist
Zolner William J
Jul/Aug 2006
Pg. 281-284

Aseptic Compounding in New Zealand and the Use of Still Air Boxes
Gargiulo Derryn
, Kairuz Therese Eileen
Jul/Aug 2006
Pg. 293-295

Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations
Douglass Kate
Jul/Aug 2006
Pg. 253-261

Putting the Science Back into the "Art and Science" of Compounding
Kastango Eric S
Jul/Aug 2006
Pg. 263-268

Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate
Reed-Kane Dana
, Kirshbaum Karen
May/Jun 2006
Pg. 165-171

Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor
Fields Shannon W
May/Jun 2006
Pg. 172

Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns?
Tran Tuan
, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2006
Pg. 202-204

Standard Operating Procedure: Sterility Test for Ophthalmic Solutions
Allen Loyd V Jr
May/Jun 2006
Pg. 218

Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2
Wagner James T
May/Jun 2006
Pg. 208-211

Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist
Jeffrey Megan
Mar/Apr 2006
Pg. 113-119

Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations
Dawson Michael F
Jan/Feb 2006
Pg. 36-39

How'd They Do That?
Roberts Jerrod L
Jan/Feb 2006
Pg. 46-49

Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management
Nguyen-Xuan Tho
, Griffiths William, Kern Christian, Van Gessel Elisabeth, Bonnabry Pascal
Jan/Feb 2006
Pg. 69-73

Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2005
Pg. 390

Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2005
Pg. 394

Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary)
Allen Loyd V Jr
Sep/Oct 2005
Pg. 395

Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Newton David W
Mar/Apr 2005
Pg. 127-130

PostScription: Experts Everywhere
Rahe Hank
Mar/Apr 2005
Pg. 167

USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing
Caputo Ross A
, Huffman Anne, Reich Robert
Jan/Feb 2005
Pg. 11-13

Using ACDs in the Practice of Pharmacy
Kastango Eric S
Jan/Feb 2005
Pg. 15-21

USP Chapter <797> and Preparing for a JCAHO Survey
McElhiney Linda F
Jan/Feb 2005
Pg. 23-28

Questions and Answers: USP Chapter <797> and JCAHO Compliance
Allen Loyd V Jr
Jan/Feb 2005
Pg. 29-31

A Dialogue Concerning Contamination Control Systems: Where Does the Isolator Fit In?
Vandenbroucke Johan
, Rahe Hank
Jan/Feb 2005
Pg. 33-35

Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations
Kupiec Thomas C
Jan/Feb 2005
Pg. 47-49

Barrier Isolators, Isolators, and Glove Boxes--What's the Difference?
Rahe Hank
Jan/Feb 2005
Pg. 53-56

Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2004
Pg. 466-467

Calculations
Prince Shelly J
Nov/Dec 2004
Pg. 468

Quality-Control Analytical Methods: Allowable Endotoxic Levels in Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2004
Pg. 479-485

Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating
Kastango Eric S
Sep/Oct 2004
Pg. 393-397

PreScription - Categories of Pharmaceutial Compounding
Allen Loyd V Jr
Jul/Aug 2004
Pg. 242

A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Newton David W
, Trissel Lawrence A
Jul/Aug 2004
Pg. 251-263

Clonidine HCl 1.5-mg/mL Injection
Allen Loyd V Jr
May/Jun 2004
Pg. 216

Fluorouracil 1% Ophthalmic Solution
Allen Loyd V Jr
May/Jun 2004
Pg. 217

Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection
Allen Loyd V Jr
May/Jun 2004
Pg. 220

Testosterone Propionate 100-mg/mL in Oil Injection
Allen Loyd V Jr
May/Jun 2004
Pg. 222

Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs.
Xu Quanyun A
, Trissel Lawrence A, Pham Lien
May/Jun 2004
Pg. 228-230

Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction.
Trissel Lawrence A
, Zhang Yanping
May/Jun 2004
Pg. 231-235

Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours.
Musami Patrick
, Stewart James T, Taylor E Will
May/Jun 2004
Pg. 236-239

Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Rahe Hank
Mar/Apr 2004
Pg. 89-94

Netilmicin 0.455% Ophthalmic Solution
Allen Loyd V Jr
Mar/Apr 2004
Pg. 138

Pyridoxine HCl 100-mg/mL Injection, Preservative Free
Allen Loyd V Jr
Mar/Apr 2004
Pg. 139

Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion
Gupta Vishnu D
Mar/Apr 2004
Pg. 153-155

Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags
Lebrun John
, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M
Mar/Apr 2004
Pg. 156-159

PostScription: Cleanroom Standards
Fitzpatrick Mike
, Goldstein Ken
Mar/Apr 2004
Pg. 160

Glycerin 50% Injection
Allen Loyd V Jr
Jan/Feb 2004
Pg. 54

Hydrochloric Acid 0.1-N Injection
Allen Loyd V Jr
Jan/Feb 2004
Pg. 55

Phenol 5%-in-Oil Injection
Allen Loyd V Jr
Jan/Feb 2004
Pg. 57

Vancomycin HCl and Heparin Sodium Injection
Allen Loyd V Jr
Jan/Feb 2004
Pg. 60

Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours
Musami Patrick
, Stewart James T, Taylor E Will
Jan/Feb 2004
Pg. 73-76

Containment of Hazardous Particulates in the Compounding Pharmacy
Allen Loyd V Jr
Jul/Aug 2003
Pg. 281-285

Stability of Amikacin Sulfate in AutoDose Infusion System Bags
Zhang Yanping
, Trissel Lawrence A
May/Jun 2003
Pg. 230-232

Autoclaves for the Sterilization of Compounded Parenteral Products
Rahe Hank
Mar/Apr 2003
Pg. 114-116

Technology Spotlight: Barrier Isolators
Moussa Magdy
, Rahe Hank, Lo Katharine
Jan/Feb 2003
Pg. 42-43

Comparison of Endotoxin Testing Methods for Pharmaceutical Products
Joiner Timothy J
, Kraus Paul F, Kupiec Thomas C
Nov/Dec 2002
Pg. 408-409

View Sample
Book Review: Sterile Compounding
Reed-Kane Dana
Nov/Dec 2002
Pg. 414

Sterile Compounding of Respiratory Inhalation Solutions
Roberts Rob
, Moore Eddie
Nov/Dec 2002
Pg. 415-417

Benzalkonium Chloride 1:750 Solution for Cold Disinfection
Allen Loyd V Jr
Nov/Dec 2002
Pg. 448

Furosemide 10-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2002
Pg. 453

Phenobarbital Sodium 130-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2002
Pg. 457

Cleaning and Disinfection
Allen Loyd V Jr
Nov/Dec 2002
Pg. 466-467

Sterilization of Talc for Use in Pleurodesis
Fehr Richard
, Henke Michelle, Ashworth Lisa D
Mar/Apr 2002
Pg. 140-141

New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems
Kastango Eric S
, Hadaway Lynn
Jan/Feb 2002
Pg. 55-57

Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures
Karolchyk Scott
Nov/Dec 2001
Pg. 422-423

Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution
Allen Loyd V Jr
Nov/Dec 2001
Pg. 455

New Perspectives on Vancomycin Use in Home Care, Part 1
Kastango Eric S
, Hadaway Lynn
Nov/Dec 2001
Pg. 465-469

Cross-contamination in Porcelain Mortars
Bauer-Brandl Annette
, Falck Astrid, Ingebrigtsen Lars, Nilsen Cathrina
Nov/Dec 2001
Pg. 476-479

Quality Assurance for Sterile Products
Kastango Eric S
, Douglass Kate
Jul/Aug 2001
Pg. 246-253

Sterile Compounding with Barrier-Isolation Technology
Rahe Hank
Jul/Aug 2001
Pg. 254-258

Bacterial Endotoxins and Pyrogens
Jones Marty
Jul/Aug 2001
Pg. 259-263

Evolution of the United States Pharmacopeia Chapter <1206>: "Sterile Preparations - Pharmacy Practices"
Okeke Claudia C
, Barletta Frank, Newton David W, Allen Loyd V Jr
Jul/Aug 2001
Pg. 265-267

Sterile Compounding: Excerpts from the Reviews of Current Published Literature
MacCara Mary E
Jul/Aug 2001
Pg. 278-279

Analytical Testing Facilities and Products
Hudson Sonora
Jul/Aug 2001
Pg. 284-286

Maintenance of the Cleanroom
Allen Loyd V Jr
Jul/Aug 2001
Pg. 313

Sterile-Product Preparations: Mix or Buy?
Kastango Eric S
Jan/Feb 2001
Pg. 59-63

Short Communication: Compounding for Implantable Pumps
Molitor Richard
Jul/Aug 2000
Pg. 280

Dry Heat Sterilization of Parenteral Oil Vehicles
Kupiec Thomas C
, Matthews Parrish, Ahmad Riaz
May/Jun 2000
Pg. 223-224

Compounding Intrathecal Medications
Vidrine Eric
Jan/Feb 2000
Pg. 24-25

Standard Operating Procedure: Quality Assessment for Injectable Solutions
Allen Loyd V Jr
Sep/Oct 1999
Pg. 406-407

Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding
Kastango Eric S
, Douglass Kate
Jul/Aug 1999
Pg. 253-258

Sterilization and Depyrogenation Principles and Methods
Akers Michael J
Jul/Aug 1999
Pg. 263-269

Sterile Product Compounding: A Comparison of ASHP and USP Guidelines
Lima Hetty A
Jul/Aug 1999
Pg. 270-273

Y-Site Stability of Fosphenytoin and Sodium Phenobarbital
English Brett A
, Riggs Robert M, Webster Andrew A, Benner Kimberly W
Jan/Feb 1999
Pg. 64-66

Testing for Bacterial Endotoxins
Jelinek Todd
Sep/Oct 1998
Pg. 379

Ophthalmic Compounding: Techniques for Achieving Sterility
Leiter Charles W
May/Jun 1998
Pg. 189

Preservation, Sterilization, and Sterility Testing of Ophthalmic Preparations
Allen Loyd V Jr
May/Jun 1998
Pg. 192-195

An Automated Process for Batch Preparation of Epidural Solutions Containing Bupivacaine Hydrochloride and Fentanyl Citrate
Rice Stephen P
May/Jun 1998
Pg. 214-215

General Aseptic Procedures Used at a Laminar Airflow Workbench
Allen Loyd V Jr
May/Jun 1998
Pg. 242

Return to Top